Journal of Nuclear Medicine honors top articles for 2001

July 22, 2002

Reston, Virginia -- The Journal of Nuclear Medicine has selected a new PET tracer, and a cost saving basic research tool as the outstanding nuclear medicine research articles for 2001. According to JNM, the research reported in these articles represents cutting edge findings with the potential to significantly impact the field of nuclear medicine. Dr. Tom Miller, Chair of the SNM's Scientific Program Committee made the announcement during the recent Society of Nuclear Medicine 49th Annual Meeting in Los Angeles, California. Dr. Martin Sandler, Editor in Chief of the Journal of Nuclear Medicine, which has just been recognized as the leading nuclear medicine journal by ISI Journal Citation Reports, presented the awards.

Under clinical investigations, first prize was awarded to: Timothy R. DeGrado, Steve W. Baldwin, Shuyan Wang, Matthew D. Orr, Ray P. Liao, Henry S. Friedman, Robert Reiman, David T. Price, and R. Edward Coleman for their article "Synthesis and Evaluation of 18F-Labeled Choline Analogs as Oncologic PET Tracers," which appeared in the JNM in December 2001. J. Nucl.Med 2001 42:1805-1814. According to the JNM, the authors' success in the synthesis of 18F Choline is a significant advancement in the development of radiopharmaceuticals for clinical use. The current radiotracer, 18F FDG, while very useful in many situations, has substantial limitations in oncological imaging because of its inability to detect very small tumors, to visualize brain and intrapelvic tumors, and to differentiate between malignancies and chronic inflammation.

Second prize went to Tali Sharir, Guideo German, Xingping Kang, Howard C. Lewin, Romalisa Miranda, Ishac Cohen, Raluca D. Agafitei, John D. Friedman, and Daniel S. Berman for their article "Prediction of Myocardial Infarction Versus Cardiac Death by Gated Myocardial Perfusion SPECT: Risk Stratification by the Amount of Stress-Induced Ischemia and the Poststress Ejection Fraction," which appeared in the Journal of Nuclear Medicine in June of 2001. J. Nucl. Med. 2001 42: 831-837.

Under the basic science investigations, first prize went to: Jan B.A. Habraken, Kora deBruin, Morgan Shehata, Jan Booij, Roel Bennink, Berthe L.F. van Eck Smit, and Elinor Buemann Sokole for their article "Evaluation of High-Resolution Pinhole SPECT Using a Small Rotating Animal" which appeared in the December, 2001 issue of the JNM. J. Nucl. Med. 2001 42: 1863-1869 By using a rotating object and a fixed collimated camera head, the researchers have made the high-resolution SPECT imaging of small animals possible. The ability to use pinhole SPECT could have significant cost-saving benefits for research in regard to purchasing laboratory specimens.

Second prize went to Lars-Eric Adam, Joel S. Karp, Margaret E. Daube-Witherspoon, and Robin J. Smith For their article: "Performance of a Whole-Body PET Scanner Using Curve-Plate NaI(T1) Detectors," which also appeared in the December issue. J. Nucl. Med. 2001 42: 1821-1830

According to newly released figures by the ISI Journal Citation Reports, the organization which tracks scientific journals, The Journal of Nuclear Medicine is the highest rated journal in nuclear medicine, and among the top 5% among the 81 journals in medical imaging. The Journal of Nuclear Medicine, the publication of the Society of Nuclear Medicine, is the recognized leader in communicating high-quality, peer-reviewed research of interest to the nuclear medicine community. Journal of Nuclear Medicine readers include nuclear medicine physicians, technologists, physicists, scientists and researchers.
For more information on the Journal of Nuclear Medicine contact: Becky Haines,, or Susan Alexander,, Journal of Nuclear Medicine, 1850 Samuel Morse Drive Reston, VA 20190, 703-708-9000.

Copies of this year's award winning articles are available free of charge online at Copies of other articles appearing in past issues of The Journal of Nuclear Medicine are also available at that site. Print copies can be obtained at $15 per copy by contacting the SNM Service Center, Society of Nuclear Medicine, 1850 Samuel Morse Drive, Reston, VA 20190-5315; phone: (703) 326-1186; fax: (703) 708-9015; e-mail: A yearly subscription to the journal is $170. A journal subscription is a member benefit of the Society of Nuclear Medicine.

Society of Nuclear Medicine

Related Nuclear Medicine Articles from Brightsurf:

Nuclear medicine and COVID-19: New content from The Journal of Nuclear Medicine
In one of five new COVID-19-related articles and commentaries published in the June issue of The Journal of Nuclear Medicine, Johnese Spisso discusses how the UCLA Hospital System has dealt with the pandemic.

Story tips: Shuffling atoms, thinning forests, fusion assembly and nuclear medicine
ORNL Story Tips: Shuffling atoms, thinning forests, fusion assembly and nuclear medicine.

Global nuclear medicine community shares COVID-19 strategies and experiences
In an effort to provide safer working environments for nuclear medicine professionals and their patients, clinics across five continents have shared their approaches to containing the spread of COVID-19 in a series of editorials, published ahead of print in The Journal of Nuclear Medicine.

Influence of the Journal of Nuclear Medicine jumps 25%
The Journal of Nuclear Medicine again ranks among the top 5 medical imaging journals in the world.

Nuclear medicine PSMA-targeted study offers new options for cancer theranostics worldwide
Research presented at the 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) describes a new class of radiopharmaceuticals, named radiohybrids (rh), that offer a fresh perspective on cancer imaging and radioligand therapy (theranostics).

Nuclear medicine imaging monitors effectiveness of therapy for melanoma patients
Nuclear medicine imaging with PET/CT can monitor the effectiveness of immunotherapy treatment for metastatic melanoma and predict outcome.

Prostate cancer radiotherapy more precisely targeted with nuclear medicine imaging
A nuclear medicine imaging procedure can pinpoint prostate cancer with superior accuracy, allowing more precisely targeted treatment, according to new research featured in the November 2018 issue of The Journal of Nuclear Medicine.

New nuclear medicine tracer will help study the aging brain
A new PET imaging radiotracer could help researchers understand neurodegenerative disease and the aging brain.

New nuclear medicine imaging method shows strong potential for cancer imaging
A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy.

New nuclear medicine technique could help tackle brain disease
A new molecular imaging method can monitor the success of gene therapy in all areas of the brain, potentially allowing physicians to more effectively tackle brain conditions such as Parkinson's disease, Alzheimer's disease and multiple sclerosis.

Read More: Nuclear Medicine News and Nuclear Medicine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to